Company / Free Cash Flow
REGENXBIO Inc. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$126.4M
FY2025
5-year range
-$238.2M / -$119.4M
FY2021-FY2025
Trend
+28.0%
vs FY2024
Sector context
#120 of 194
Health Care
What the data says
At -$126M, REGENXBIO Inc.'s free cash flow ranks #120 of 194 in the Health Care sector. Free Cash Flow has increased for 3 consecutive years, from -$238M in FY2022 to -$126M in FY2025.
Based on SEC 10-K filings.
-$126M in FY2025.
Improved from -$228M to -$126M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#120 of 194 in Health CareTop 62% of 194This company -$126.4M Sector average $470.8M
▼
-126.8% below sector average
Key checks
Key Insights
- REGENXBIO Inc.'s free cash flow has grown for 3 consecutive years.
- In FY2025, free cash flow increased 28.0% year-over-year.
- Ranks #120 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score -2.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$126.4M | +28.0% |
| FY2024 | -$175.6M | +23.1% |
| FY2023 | -$228.4M | +4.1% |
| FY2022 | -$238.2M | -99.5% |
| FY2021 | -$119.4M | -230.7% |
| FY2020 | $91.4M | +240.2% |
| FY2019 | -$65.2M | -171.3% |
| FY2018 | $91.4M | +240.2% |
| FY2017 | -$65.2M | -2130.5% |
| FY2016 | -$2.9M | +17.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026